The investigator's primary aim is to evaluate polypharmacy-associated adverse drug reactions (ADR) in a pilot study of at-risk patients using state-of-the-art …

Adverse Drug Reaction (ADR)Polypharmacy Patients

~Estimated

~$10 – $750

Texas A&M UniversityNCT06766071

Observational

Promoting Healthy Aging Among WTC Responders: Frailty Trajectories And Intervention Strategies

By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions an…

Polypharmacy

~Estimated

~$10 – $6,250

Icahn School of Medicine at Mount SinaiNCT07022990